Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by AURIS HUEN and MADELEINE DUVIC.
AURIS HUEN
Connection Strength
1.644
MADELEINE DUVIC
  1. On the Way to Curing Advanced-Stage Mycosis Fungoides/S?zary Syndrome. Clin Lymphoma Myeloma Leuk. 2024 Dec; 24(12):827-836.
    View in: PubMed
    Score: 0.242
  2. Complete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory s?zary syndrome. Invest New Drugs. 2023 04; 41(2):350-355.
    View in: PubMed
    Score: 0.221
  3. Renal Cell Carcinoma Associated with Mycosis Fungoides: A Paraneoplastic Syndrome. Case Rep Nephrol. 2020; 2020:8897183.
    View in: PubMed
    Score: 0.187
  4. Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients. Arch Dermatol Res. 2020 May; 312(4):283-288.
    View in: PubMed
    Score: 0.176
  5. Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results. JAMA Dermatol. 2017 12 01; 153(12):1302-1306.
    View in: PubMed
    Score: 0.153
  6. Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series. Cancer. 2013 Feb 15; 119(4):825-31.
    View in: PubMed
    Score: 0.106
  7. ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and S?zary Syndrome. Transplant Cell Ther. 2024 Nov; 30(11):1047-1060.
    View in: PubMed
    Score: 0.061
  8. Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol. 2024 Jul 02.
    View in: PubMed
    Score: 0.060
  9. Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells. 2024 Feb 27; 13(5).
    View in: PubMed
    Score: 0.059
  10. Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma. Adv Radiat Oncol. 2023 Nov-Dec; 8(6):101279.
    View in: PubMed
    Score: 0.056
  11. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 09 01; 158(9):1031-1039.
    View in: PubMed
    Score: 0.053
  12. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? Virchows Arch. 2021 Aug; 479(2):377-383.
    View in: PubMed
    Score: 0.048
  13. Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2021 02; 21(2):97-105.
    View in: PubMed
    Score: 0.046
  14. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/S?zary syndrome than quantification of CD26- or CD7- CD4+ T-cells. Cytometry B Clin Cytom. 2021 03; 100(2):183-191.
    View in: PubMed
    Score: 0.046
  15. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. Eur J Cancer. 2020 07; 133:120-130.
    View in: PubMed
    Score: 0.045
  16. Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features. J Cutan Pathol. 2019 Nov; 46(11):872-877.
    View in: PubMed
    Score: 0.043
  17. Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement. Case Rep Oncol. 2018 Sep-Dec; 11(3):721-728.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.